Background: In asthma, exhaled nitric oxide (F E NO) is a clinically established biomarker of airway T2 inflammation and an indicator for anti-inflammatory therapy. Object
SIC: Specific inhalation challenge; HMW: High molecular weight; LMW: Low molecular weight. * Papers with a single case not included. ** Healthy controls. *** Agents not specified.